RBFOX3 and ischemic stroke: Recently, we demonstrated that the ELV precursors C-32:6 and C-34:6 administered intranasally after experimental ischemic stroke improved behavior, decreased T2WI lesion volume, and increased SMI-71 positive blood vessels and NeuN positive neurons, indicating BBB protection and neurogenesis [16].